The core innovation is deceptively simple. Rather than relying on invasive skin biopsies, blood draws or urine collection, the protocol uses hairs plucked with intact follicles, ideally in the anagen or growth phase, when the follicle is rich in proliferative keratinocytes. Once plucked, the hairs are placed in a kit and can be mailed over long distances without refrigeration. In the laboratory, keratinocytes are released from the follicles by trypsinization, an enzymatic digestion that separates the cells from the hair shaft, and are then cultured under conditions that preserve their proliferative capacity. The authors report that samples remain stable for days at ambient temperature, provided standard biosafety precautions are observed, which makes ordinary postal and courier services viable conduits for human biological material.

Why does the choice of starting cell matter so much? Induced pluripotent stem cells, first generated by Shinya Yamanaka and colleagues in 2007 through the forced expression of defined transcription factors, can differentiate into all three embryonic lineages, including the neural lineage that gives rise to neurons and glia. But the quality and efficiency of reprogramming depend heavily on the source cell. Dermal fibroblasts require a punch biopsy, an uncomfortable procedure that typically must be performed by a clinician. Peripheral blood mononuclear cells require venipuncture and careful handling, and although blood held at room temperature has been used successfully, the window is limited. Renal epithelial cells from urine are noninvasive but yield variable numbers of cells and are not suitable for every donor. Keratinocytes, by contrast, reprogram efficiently, and hair plucking is essentially painless.

The Yale team’s protocol lowers the technical barrier even further by requiring fewer follicles than previous hair-based approaches. Earlier methods for isolating keratinocytes from plucked hair existed, including protocols published by Aasen and colleagues in 2008 and 2010, but they generally demanded either fresh local collection or specialized handling. The new kit-based workflow explicitly anticipates the realities of remote participation: a donor, a family member or a healthcare provider can perform the collection after watching a short instructional video that accompanies the protocol, and the resulting sample tolerates the delays of long-distance shipping. This matters enormously for rare disease research, where patients are geographically dispersed and where systematic reviews have documented substantial inequities in access to clinical genetic services.

Once the keratinocytes arrive in the laboratory, the workflow follows a well-trodden but carefully optimized path. The cells are expanded in culture, with the Rho kinase inhibitor Y-27632 playing a supporting role in improving survival, a trick borrowed from the keratinocyte literature where ROCK inhibition prolongs the lifespan of adult cells in vitro. Reprogramming then converts the keratinocytes into iPS cells, a process the protocol completes within roughly two months of receiving the hair samples. Notably, the authors emphasize that the procedure requires only basic familiarity with mammalian cell culture techniques and no specialized equipment beyond what a standard cell biology laboratory already possesses. That accessibility is a deliberate design choice: the protocol is written to be executable by labs that have never worked with human iPS cells before.

Quality control is built into the workflow. The published protocol includes characterization steps confirming that the resulting iPS cells express canonical pluripotency markers, retain a normal karyotype, and can differentiate into all three germ layers, including neural lineages. The authors demonstrate the full pipeline by generating cerebral organoids, three-dimensional self-organizing cultures that recapitulate key features of early human brain development. Organoid generation from the iPS cells takes 30 to 40 days and requires one piece of specialized equipment, an orbital shaker, which keeps the growing organoids suspended and nourished in culture. Whole-mount imaging and immunostaining confirm that the organoids contain the expected neural cell populations, establishing that hair-derived iPS cells are fully competent for demanding three-dimensional differentiation protocols.

The protocol did not emerge in a vacuum. It was developed and refined in the course of a primary research study, published in Nature in 2025, in which Zhang and colleagues showed that dysregulation of mTOR signalling is a converging mechanism in lissencephaly, a severe malformation of cortical development. For that study, the team needed iPS cells and brain organoids from patients with rare neurogenetic conditions, many of whom lived far from any research center. The kit-based hair collection method proved to be the practical answer, and the new Nature Protocols article distills that hard-won experience into a form other laboratories can adopt directly. The authors acknowledge the patients and families who contributed samples, underscoring that the method was shaped by the needs of the very people it is meant to serve.

The broader implications reach into drug development, disease modeling and eventually cell therapy. Human iPS cell-derived models allow researchers to study cellular and molecular mechanisms of disease in genuinely human tissue, something animal models often fail to capture, and cerebral organoids in particular have transformed the study of neurodevelopmental disorders since Lancaster and colleagues first described them in 2013. By making the front end of that pipeline, patient sample acquisition, dramatically easier, the Yale protocol could expand the diversity of genetic backgrounds represented in organoid studies, a long-standing concern in a field where most cell lines derive from patients already connected to major academic medical centers. Populations in low-resource settings, pediatric patients for whom blood draws are difficult, and elderly donors with fragile veins all stand to benefit from a collection method that requires nothing more than a pair of tweezers and a mailing envelope.

There are, of course, practical considerations. The protocol specifies that hairs must be plucked with follicles intact, since the follicle bulb contains the keratinocyte population of interest, and the accompanying video walks collectors through identifying suitable anagen-phase hairs. Shipping times must remain within the window during which the keratinocytes stay viable at ambient temperature, and laboratories must handle all human material under appropriate biosafety procedures. Reprogramming efficiency, while generally high for keratinocytes, still varies between donors, as it does for all somatic cell sources. Yet the authors argue that the advantages outweigh these constraints: the method is noninvasive, the samples are robust, the timeline is competitive, and the equipment requirements are minimal. As personalized medicine pushes toward models built from each patient’s own genome, protocols like this one may determine who gets to participate. A technology that turns a handful of plucked hairs into a patient-specific mini brain, mailed across continents in an ordinary package, is a striking reminder that sometimes the most transformative tools in biomedicine are also the most humble.

Subject of Research: A kit-based protocol for remote collection of hair follicle keratinocytes and their reprogramming into induced pluripotent stem cells for cerebral organoid generation

Article Title: Kit-based remote collection and isolation of human reprogrammable somatic cells for generation of induced pluripotent stem cells and cerebral organoids

Article References: Cheng, I. Q., Ruiz, J. F., Casalino, E. K., Zhang, C., & Louvi, A. (2026). Kit-based remote collection and isolation of human reprogrammable somatic cells for generation of induced pluripotent stem cells and cerebral organoids. Nature Protocols. https://doi.org/10.1038/s41596-026-01440-z

Image Credits: AI Generated

DOI: 10.1038/s41596-026-01440-z

Keywords: induced pluripotent stem cells, keratinocytes, hair follicles, cerebral organoids, reprogramming, remote sample collection, disease modeling, personalized medicine, neurodevelopmental disorders, Nature Protocols, cell culture, lissencephaly